In people with type 2 diabetes and normoalbuminuria, a high-risk score from the urinary proteomic classifier CKD273 was associated with an increased risk of progression to microalbuminuria over a median of 2.5 years, independent of clinical characteristics. However, spironolactone did not prevent progression to microalbuminuria in high-risk patients.
Addressing target audiences and expressing needs
- To raise awareness and possibly influence policy
- Use of research Infrastructure
- Collaboration
- Fellowship to advance my/our research
- EU and Member State Policy-makers
- Research and Technology Organisations
- Academia/ Universities
Result submitted to Horizon Results Platform by ACADEMISCH ZIEKENHUIS GRONINGEN

